Support for GHK-Cus systemic effects is based principally on animal and in vitro studies, but the findings give reason to be optimistic about its potential as an injectable treatment
A: Licensed healthcare professionals (physicians, nurses, pharmacists, dentists, veterinarians, PAs, NPs, etc.), authorized healthcare institutions (hospitals, clinics, compounding pharmacies, EMS agencies), and licensed distributors can purchase from Mountainside Medical
Youre not alone
Tirzepatide (Zepbound) is also FDA-approved for chronic weight management (with criteria) and has strong trial evidence for substantial average weight loss
Liu HT and Kuo HC: Intravesical botulinum toxin a injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis
doi:10.1016/S0079-6603(01)70012-8